SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Summit Technology (BEAM) -- Ignore unavailable to you. Want to Upgrade?


To: Walter in HK who wrote (1124)3/24/1999 10:34:00 PM
From: GBT  Read Replies (4) | Respond to of 1386
 
BEAM take out a one time litigation settlement of 34.4 million and a 2 million sale of an asset and this company has less than a million in income in 98. For the last quarter if you take out the 2 million
for a one time sale of an asset and a one time accounting change that
added .9 million you can subtract 60% of their earnings per share.
Nice year but how many 30 million settlements can you rely on?

Income from continuing operations before the cumulative effect of accounting change in 1998 was $36.7 million, or $1.17 per share, which includes a litigation settlement of $34.4 million, net of related expenses and the $2.0 million gain on the sale of assets. Income from continuing operations for 1997 was $0.8 million, or $0.03 per share. Net income in 1998 was $27.6 million or $0.88 per share compared to $21.4 million or $0.68 per share in 1997. Net income in 1997 includes a favorable impact of $20.6 million related to discontinued operations

Income from continuing operations for the fourth quarter of 1998 was $3.6 million, or $0.12 per share, as compared to a loss from continuing operations of $0.4 million, or $(0.01) per share, in the fourth quarter of 1997. Income from continuing operations in the fourth quarter 1998 was favorably impacted by a gain of $2.0 million from the sale of assets related to a cardiovascular laser technology that Summit was previously developing. Net income in the fourth quarter 1998 was $4.5 million, or $0.15 per share, which included a gain of $0.9 million on the sale of the Company's vision correction centers, compared to a net loss of $0.4 million, or $(0.01) per share, in the prior year.